"Mycobacterium tilburgii" infections [12]

Emerging Infectious Diseases

Volumn 12, Issue 3, 2006, Pages 532-534

  Wagner, Dirk ^a   Vos, Margreet C ^b,c   Buiting, Anton G M ^b   Serr, Annerose ^a   Bergmans, Anneke M C ^d   Kern, Winfried V ^a   Schouls, Leo M ^e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c TweeSteden Hospital   (Netherlands)

^d Franciscus Hospital   (Netherlands)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIBOSOME RNA; RIFABUTIN; RIFAMPICIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIMICROBIAL THERAPY; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CASE REPORT; COLONOSCOPY; CYSTOSCOPY; DNA SEQUENCE; DYSURIA; FEMALE; GENE SEQUENCE; HEMATURIA; HUMAN; IMMUNE DEFICIENCY; LETTER; MACROPHAGE; MALE; MYCOBACTERIOSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; TAXONOMIC IDENTIFICATION; TREATMENT DURATION;

EID: 33644555853     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1203.051139     Document Type: Letter

References (10)

1. Brown-Elliott BA, Griffith DE, Wallace RJ Jr. Newly described or emerging human species of nontuberculous mycobacteria. Infect Dis Clin North Am. 2002;16:187-220.
2. Wagner D, Young LS. Nontuberculous mycobacterial infections. Infection. 2004;32:257-70.
3. Kirschner P, Springer B, Vogel U, Meier A, Wrede A, Kiekenbeck M, et al. Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J Clin Microbiol. 1993;31:2882-9.
4. Buiting A, Vos M, Bergmans A, Schouls L. A new mycobacterial species causing disseminated infection. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco 1995; Abstract K45. Washington: American Society for Microbiology; 1995.
5. Realini L, De RK, Hirschel B, Portaels F: Blood and charcoal added to acidified agar media promote the growth of Mycobacterium genavense. Diagn Microbiol Infect Dis. 1999;34:45-50.
6. Selvarangan R, Wu WK, Nguyen TT, Carlson LD, Wallis CK, Stiglich SK, et al. Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol. 2004;42:52-9.
7. Wayne LG, Good RC, Bottger EC, Butler R, Dorsch M, Ezaki T, et al. Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol. 1996;46:280-97.
8. Hughes MS, James G, Ball N, Scally M, Malik R, Wigney DI, et al. Identification by 16S rRNA gene analyses of a potential novel mycobacterial species as an etiological agent of canine leproid granuloma syndrome. J Clin Microbiol. 2000;38:953-9.
9. Richter E, Rusch-Gerdes S, Niemann S, Stoehr A, Plettenberg A. Detection, identification, and treatment of a novel, non-cultivable Mycobacterium species in an HIV patient. AIDS. 2000;14:1667-8.
10. Kolditz M, Halank M, Spornraft-Ragaller P, Schmidt H, Höffken G: Localized pulmonary infection associated with Mycobacterium tilburgii in an HIV-infected patient. Infection. 2005;33:278-81.